Stock CCAP CRESCENT CAPITAL BDC, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Crescent Capital BDC, Inc.

Equities

CCAP

US2256551092

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-21 EDT 		5-day change 1st Jan Change
18.72 USD -0.32% Intraday chart for Crescent Capital BDC, Inc. +1.03% +7.71%
06-12 Transcript : Crescent Capital BDC, Inc. - Analyst/Investor Day
06-04 Crescent Capital BDC, Inc. Enter Into Seventh Amendment to Loan and Security Agreement CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Keefe, Bruyette & Woods Adjusts Price Target on Crescent Capital BDC to $19 From $18.50, Maintains Outperform Rating
MT
Wells Fargo Adjusts Price Target on Crescent Capital BDC to $18 From $16.50, Maintains Equal-Weight Rating
MT
Oppenheimer Adjusts Crescent Capital BDC Price Target to $20 From $19, Maintains Outperform Rating
MT
Oppenheimer Adjusts Crescent Capital BDC Price Target to $19 From $18, Maintains Outperform Rating
MT
Wells Fargo Raises Price Target on Crescent Capital BDC to $16.50 From $16, Maintains Equalweight Rating
MT
Wells Fargo Downgrades Crescent Capital BDC to Equal-Weight From Overweight, Trims Price Target to $16 From $16.50
MT
Keefe, Bruyette & Woods Starts Crescent Capital BDC at Outperform With $18 Price Target
MT
Oppenheimer Adjusts Crescent Capital BDC Price Target to $18 From $19, Maintains Outperform Rating
MT
Raymond James Adjusts Crescent Capital's Price Target to $18 from $20.50, Retains Outperform Rating
MT
Oppenheimer Upgrades Crescent Capital BDC to Outperform From Perform, Trims Price Target to $19 From $20
MT
Raymond James Trims Crescent Capital's Price Target to $20.50 From $21, Maintains Outperform Rating
MT
Wells Fargo Adjusts Crescent Capital BDC's Price Target to $18.50 from $19.50, Keeps Overweight Rating
MT
Wells Fargo Starts Crescent Capital BDC at Overweight With $19.50 Price Target
MT
BofA Securities Starts Crescent Capital BDC at Buy With $19.50 Price Target
MT
CRESCENT CAPITAL BDC : Oppenheimer Lifts Price Target on Crescent Capital BDC to $20 From $19, Keeps Perform Rating
MT
CRESCENT CAPITAL BDC : Oppenheimer Initiates Coverage on Crescent Capital BDC With Perform Rating, $19 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CCAP Stock
  4. News Crescent Capital BDC, Inc.
  5. Analyst Reco.